Success Metrics

Clinical Success Rate
87.7%

Based on 50 completed trials

Completion Rate
88%(50/57)
Active Trials
23(20%)
Results Posted
44%(22 trials)
Terminated
7(6%)

Phase Distribution

Ph phase_2
5
4%
Ph early_phase_1
1
1%
Ph phase_1
2
2%
Ph not_applicable
106
91%
Ph phase_4
2
2%

Phase Distribution

3

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution116 total trials
Early Phase 1First-in-human
1(0.9%)
Phase 1Safety & dosage
2(1.7%)
Phase 2Efficacy & side effects
5(4.3%)
Phase 4Post-market surveillance
2(1.7%)
N/ANon-phased studies
106(91.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.0%

50 of 61 finished

Non-Completion Rate

18.0%

11 ended early

Currently Active

23

trials recruiting

Total Trials

117

all time

Status Distribution
Active(30)
Completed(50)
Terminated(11)
Other(26)

Detailed Status

Completed50
unknown26
Recruiting21
Terminated7
Not yet recruiting6
Withdrawn4

Development Timeline

Analytics

Development Status

Total Trials
117
Active
23
Success Rate
87.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.9%)
Phase 12 (1.7%)
Phase 25 (4.3%)
Phase 42 (1.7%)
N/A106 (91.4%)

Trials by Status

not_yet_recruiting65%
recruiting2118%
enrolling_by_invitation11%
completed5043%
terminated76%
unknown2622%
withdrawn43%
active_not_recruiting22%

Recent Activity

Clinical Trials (117)

Showing 20 of 117 trialsScroll for more
NCT05097586Not Applicable

RCT of At-Home tDCS for Depression in Pregnancy

Recruiting
NCT05092516Not Applicable

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

Active Not Recruiting
NCT06432465Not Applicable

tDCS to Decrease Opioid Relapse (UH3)

Recruiting
NCT06901687Phase 2

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

Recruiting
NCT05998031Not Applicable

A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients

Recruiting
NCT05311956Not Applicable

Pain Reduction Using NEurostimulation Study

Active Not Recruiting
NCT07576543Phase 4

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Not Yet Recruiting
NCT07576517Phase 4

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Not Yet Recruiting
NCT05390853Not Applicable

Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients

Terminated
NCT07212829Not Applicable

The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pain

Recruiting
NCT04120714Not Applicable

Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming

Recruiting
NCT07141979Not Applicable

Effects of tDCS on Cognitive Flexibility and EEG Oscillations in Orthorexia Nervosa

Recruiting
NCT06885606Not Applicable

The Use of tDCS for Vaping Reduction

Recruiting
NCT07246993Not Applicable

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

Recruiting
NCT06369532Not Applicable

Combination of Neurostimulation and Psychotherapy to Stop Worrying

Recruiting
NCT06453980Not Applicable

Multimodal Investigation of Neural Plasticity

Recruiting
NCT07442786Not Applicable

Clustered tDCS Sessions for Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder

Not Yet Recruiting
NCT07092280Not Applicable

Transcranial Direct Current Stimulation in Children With Autism

Recruiting
NCT05240352Not Applicable

Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Recruiting
NCT07404319Not Applicable

Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
117